Safety of palivizumab in preterm infants 29 to 32 weeks' gestational age without chronic lung disease to prevent serious respiratory syncytial virus infection (Q40556092)
Jump to navigation
Jump to search
scientific article published on 24 June 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety of palivizumab in preterm infants 29 to 32 weeks' gestational age without chronic lung disease to prevent serious respiratory syncytial virus infection |
scientific article published on 24 June 2003 |
Statements
1 reference
Safety of palivizumab in preterm infants 29 to 32 weeks' gestational age without chronic lung disease to prevent serious respiratory syncytial virus infection (English)
1 reference
Groothuis JR
1 reference
24 June 2003
1 reference
1 reference
22
1 reference
7
1 reference
414-417
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference